China National Accord Medicines Corp Ltd (000028) — Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd (000028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting CN¥95.44 Million (capex CN¥50.09 Million plus investments CN¥45.35 Million) from operating cash flow of CN¥1.83 Billion. Check 000028 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 26 annual periods. Explore 000028 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. For live market cap and broader valuation context, see 000028 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | CN¥476.87 Million | CN¥3.27 Billion | CN¥282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | CN¥457.64 Million | CN¥2.94 Billion | CN¥322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | CN¥665.01 Million | CN¥2.56 Billion | CN¥322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | CN¥514.46 Million | CN¥1.66 Billion | CN¥370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | CN¥324.92 Million | CN¥1.50 Billion | CN¥293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | CN¥301.17 Million | CN¥2.00 Billion | CN¥245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | CN¥380.06 Million | CN¥1.32 Billion | CN¥255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | CN¥217.09 Million | CN¥1.29 Billion | CN¥204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | CN¥275.02 Million | CN¥1.47 Billion | CN¥265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | CN¥226.73 Million | CN¥1.05 Billion | CN¥190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | CN¥150.50 Million | CN¥465.03 Million | CN¥150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | CN¥193.57 Million | CN¥323.96 Million | CN¥193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | CN¥198.97 Million | CN¥227.32 Million | CN¥198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | CN¥177.99 Million | CN¥428.16 Million | CN¥177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | CN¥102.94 Million | CN¥270.85 Million | CN¥102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | CN¥84.98 Million | CN¥246.58 Million | CN¥84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | CN¥71.41 Million | CN¥87.70 Million | CN¥71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | CN¥118.22 Million | CN¥181.73 Million | CN¥118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | CN¥50.62 Million | CN¥148.28 Million | CN¥50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | CN¥14.18 Million | CN¥130.30 Million | CN¥14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | CN¥49.36 Million | CN¥81.22 Million | CN¥49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | CN¥26.90 Million | CN¥28.76 Million | CN¥26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | CN¥35.91 Million | CN¥71.16 Million | CN¥35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | CN¥21.01 Million | CN¥8.52 Million | CN¥21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | CN¥27.54 Million | CN¥22.84 Million | CN¥27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | CN¥10.38 Million | CN¥5.21 Million | CN¥10.38 Million | — |